MedAvail Holdings Inc
NASDAQ:MDVL 3:59:41 PM EDT
Divestitures / Spin-offs, Earnings Announcements
Medavail Announces Sale Of Pharmacy Assets To Cvs Pharmacy
Published: 01/26/2023 13:26 GMT
MedAvail Holdings Inc (MDVL) - Medavail Announces Sale of Pharmacy Assets to Cvs Pharmacy.
Medavail Holdings - Portion of Proceeds From Cvs Transaction Will Be Used to Paydown Company's Existing Loan Facility.
Medavail Holdings Inc - Portion of Proceeds From Cvs Transaction Will Be Used to Paydown Company's Existing Loan Facility.
Medavail Holdings Inc - Remaining Proceeds Will Be Used for Ongoing Operation of Company.
Medavail Holdings Inc - Co Currently Estimates It Will End 2022, Prior to Cvs Transaction, With Between $10 Million to $11 Million of Cash and Investments.
Medavail Holdings Inc - Estimates That It Will End 2022, Prior to Cvs Transaction, With Between $10 Million to $11 Million of Cash and Investments.
Medavail Holdings Inc - Continues to Closely Evaluate Various Financings Options, Including With Existing Shareholders.
Medavail Holdings - Currently Estimates Will Incur One-time Costs in H1 2023 Related to Restructuring to Be About $6.5 Million.
Medavail Holdings Inc - Pharmacy Records and Inventory Purchased by Cvs Will Be Transferred From Spotrx Pharmacies to Nearby Cvs Pharmacy Locations.
Medavail Holdings - Portion of Proceeds From Cvs Transaction Will Be Used to Paydown Company's Existing Loan Facility.
Medavail Holdings Inc - Portion of Proceeds From Cvs Transaction Will Be Used to Paydown Company's Existing Loan Facility.
Medavail Holdings Inc - Remaining Proceeds Will Be Used for Ongoing Operation of Company.
Medavail Holdings Inc - Co Currently Estimates It Will End 2022, Prior to Cvs Transaction, With Between $10 Million to $11 Million of Cash and Investments.
Medavail Holdings Inc - Estimates That It Will End 2022, Prior to Cvs Transaction, With Between $10 Million to $11 Million of Cash and Investments.
Medavail Holdings Inc - Continues to Closely Evaluate Various Financings Options, Including With Existing Shareholders.
Medavail Holdings - Currently Estimates Will Incur One-time Costs in H1 2023 Related to Restructuring to Be About $6.5 Million.
Medavail Holdings Inc - Pharmacy Records and Inventory Purchased by Cvs Will Be Transferred From Spotrx Pharmacies to Nearby Cvs Pharmacy Locations.
Revenue is expected to be $11.9 Million
Adjusted EPS is expected to be -$0.14
Next Quarter Revenue Guidance is expected to be $0.43 Million
Next Quarter EPS Guidance is expected to be -$0.13
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.14
Next Quarter Revenue Guidance is expected to be $0.43 Million
Next Quarter EPS Guidance is expected to be -$0.13
More details on our Analysts Page.